Harvard Bioscience Inc (HBIO) insider trading

Every open-market stock purchase and sale by Harvard Bioscience Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Insiders bought $202K over the last 12 months (4 buys).
  • Last insider buy: Stephen J Denelsky (Director), $48.7K, 7 months ago.

Last 12 months: insiders bought $202K (4 buys) and sold $0 (0 sales). Last close $8.49 on Oct 21, 2026.

Recent HBIO insider trades

DateInsiderTradeValue
Jun 9, 2026Seth Benjamin Benson (Director)Bought (not open market)—
Jun 9, 2026Stephen J Denelsky (Director)Bought (not open market)—
Jun 9, 2026Katherine A. Eade (Director)Bought (not open market)—
Jun 9, 2026Robert E. Gagnon (Director)Bought (not open market)—
Jun 9, 2026William Snider (Director)Bought (not open market)—
Mar 20, 2026John D Duke (CEO)Bought (not open market)—
Mar 20, 2026Mark T Frost (CFO)Bought (not open market)—
Mar 17, 2026Stephen J Denelsky (Director)Bought$48.7K
Mar 17, 2026William Snider (Director)Bought$41.1K
Mar 16, 2026William Snider (Director)Bought$62.5K
Mar 16, 2026John D Duke (CEO)Bought$25.1K
Mar 16, 2026Mark T Frost (CFO)Bought$25K
Dec 17, 2025William Snider (Director)Bought (not open market)—

Who's trading HBIO

Get free alerts when an insider at Harvard Bioscience Inc files a new trade →